![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1402731
Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¿¹Ãø(-2030³â) : Áö¿ªº° ºÐ¼® - Á¦Ç°º°, ½Ã¼úº°, ÃÖÁ¾»ç¿ëÀÚº°South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Forecast to 2030 - Regional Analysis - Product (Dental Bone Graft Substitute and Dental Barrier Membrane), Procedures, and End User (Hospitals, Dental Clinics, and Others) |
Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº 2022³â 4,116¸¸ ´Þ·¯¿¡¼ 2030³â 7,976¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ±â¾÷µéÀÇ Àü·«Àû °³¹ß
Á¦Ç° Ãâ½Ã, M&A, »ç¾÷ È®Àå°ú °°Àº ½ÅÈï±¹ ½ÃÀåÀÌ Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. Graft PlugÀÇ Ãâ½Ã¸¦ ¹ßÇ¥ÇÏ¸ç ¹ßÄ¡ºÎ ¹× Ä¡ÁÖ °á¼Õ ºÎÀ§ ÃæÀüÀ» À§ÇÑ »ýüÀç·á Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇß½À´Ï´Ù. 2023³â 5¿ù, ½ºÆ®¶ó¿ì¸¸Àº ½ºÀ§½º ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ GalvoSurge Dental AG¸¦ ÀμöÇß½À´Ï´Ù. 2022³â 10¿ù¿¡´Â »À, ¿¬°ñ, Á¶Á÷ Àç»ý Àü¹® ±â¾÷ °¡À̽ºÆ®¸®È÷°¡ ¹Ì±¹ ¸°Ä¡ ¹ÙÀÌ¿À·ÎÁ÷½º(Lynch Biologics)¸¦ ÀμöÇØ ÀÓÇöõÆ® ÁÖº¯¿° Ä¡·á¸¦ Áö¿øÇÏ´Â ÀÓÇöõÆ® °ü¸® ¹× À¯Áöº¸¼ö ¼Ö·ç¼ÇÀ» Àü¹®À¸·Î ÇÕ´Ï´Ù. À̹ø Àμö·Î °¡À̽ºÆ®¸®È÷ ÆÄ¸¶´Â ¸°Ä¡ ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ ÁÖ¿ä Á¦Ç°ÀÎ GEM 21S(GEM 21S´Â °ñ Çü¼º ¹× »óó Ä¡À¯¸¦ ÃËÁøÇÏ´Â ¼ºÀå ÀÎÀÚ¸¦ ±â¹ÝÀ¸·Î ÇÏ´Â Á¦Ç°)¸¦ Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡ÇÏ¿© Æ÷Æ®Æú¸®¿À¸¦ °ÈÇß½À´Ï´Ù. ¾ç»ç´Â ¶ÇÇÑ Ä¡°ú Àç»ý ±â¼ú Çõ½ÅÀ» À§ÇØ 2022³â 12¿ù Ä¡°ú¿ë ÀÓÇöõÆ® Ä¡·á Á¦Ç°À» ¼³°è, Á¦Á¶ ¹× ÆÇ¸ÅÇÏ´Â ³×¿À½º ±×·ìÀÌ ºÏÀ¯·´ Áö¿ª¿¡ »õ·Î¿î ¿µ¾÷ °ÅÁ¡À» °³¼³Çß½À´Ï´Ù. ÀÌ ½Ã¼³Àº Ä¡°ú ÀÇ·áÁø°ú ȯÀÚ¸¦ Áö¿øÇϱâ À§ÇØ 2022³â 12¿ù 1ÀÏ ºÏÀ¯·´ Áö¿ª¿¡¼ ¿µ¾÷À» ½ÃÀÛÇßÀ¸¸ç, 2021³â 1¿ù µ§Ã÷ÇöóÀÌ ½Ã·Î³ª´Â Çõ½ÅÀûÀÎ OSSIX Àç»ý ¼Ö·ç¼ÇÀÇ ¼±µµÀûÀÎ °ø±Þ¾÷üÀÎ Datum DentalÀ» ÀμöÇß½À´Ï´Ù. À̹ø Àμö·Î µ§Ã÷ÇöóÀÌ ½Ç·Î³ª´Â ´ÙÅù µ§Å»ÀÇ °·ÂÇÑ OSSIX ¹ÙÀÌ¿À¼ÒÀç Æ÷Æ®Æú¸®¿À¸¦ È®º¸ÇÒ ¼ö ÀÖ°Ô µÆ½À´Ï´Ù. ¶ÇÇÑ, ±Û¸®¸ÅÆ®¸¯½º´Â ÀÎüÀÇ ÀÚ¿¬ÀûÀÎ Äݶó°Õ »çÀÌŬ, Áï ´çȶó´Â »ýÈÇÐÀû °úÁ¤À» ¸ð¹æÇÑ ±Û¸®¸ÅÆ®¸¯½º(GLYMATRIX)¸¦ ÅëÇØ À¯µµÇÏ »À Àç»ý ¹× À¯µµÇÏ Á¶Á÷ Àç»ýÀ» À§ÇÑ OSSIX Á¦Ç°ÀÇ ±âÃʸ¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù.
Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå °³¿ä
Áß³²¹Ì ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀåÀº Ä¡°ú ÁúȯÀÇ Áõ°¡, Ä¡°ú °ü±¤ÀÇ Áõ°¡, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¾öû³ ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.
Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)
Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¼¼ºÐÈ
Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Á¦Ç°, ½Ã¼ú, ÃÖÁ¾»ç¿ëÀÚ ¹× ±¹°¡º°·Î ¼¼ºÐȵ˴ϴÙ.
Á¦Ç°À» ±âÁØÀ¸·Î Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú Ä¡°ú¿ë ¹è¸®¾î ¸âºê·¹ÀÎÀ¸·Î ±¸ºÐµÇ¸ç, 2022³â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ºÎ¹®ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
Ä¡·á¹ýÀ» ±âÁØÀ¸·Î Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº °¡À̵å ÇÏ °ñÀç»ý(GBR) Ä¡·á, °¡À̵å ÇÏ Á¶Á÷ Àç»ý(GTR) Ä¡·á, »çÀ̳ʽº ¸®ÇÁÆ® ¹× ¸´Áö ½ºÇø´ Ä¡·á, Ä¡Á¶°ñ À¶±â º¸Á¸(ARP), ºí·Ï À̽Ä, Ä¡ÁÖ Àç»ý, ¼ÒÄÏ º¸Á¸, ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2022³â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº »çÀ̳ʽº ¸®ÇÁÆ® ¹× ¸´Áö ½ºÇø´ ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº º´¿ø, Ä¡°ú Áø·á¼Ò ¹× ±âŸ·Î ºÐ·ùµÇ¸ç, Ä¡°ú Áø·á¼Ò ºÎ¹®Àº 2022³â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î´Â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ±âŸ ³²¹Ì´Â 2022³â Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀ» Áö¹èÇß½À´Ï´Ù.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Institut Straumann AG´Â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷µé Áß ÀϺÎÀÔ´Ï´Ù.
The South & Central America dental bone graft substitute and barrier membrane market is expected to grow from US$ 41.16 million in 2022 to US$ 79.76 million by 2030. It is estimated to grow at a CAGR of 8.6% from 2022 to 2030.
Strategic Developments by Market Players Fuel South & Central America Dental Bone Graft Substitute and Barrier Membrane Market
Development strategies such as product launches, mergers and acquisitions, and expansions boost the growth of the South & Central America Dental Bone Graft Substitute and Barrier Membrane Market. In April 2023, ZimVie announced the launch of RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, which helped it extend its portfolio of biomaterials that are intended for filling extraction sockets and periodontal defects. The products are commercially available in North America. In May 2023, Straumann acquired GalvoSurge Dental AG, a Swiss medical device manufacturer. The acquired company specializes in implant care and maintenance solutions to support the treatment of peri-implantitis. In October 2022, Geistlich, specialized in the regeneration of bone, cartilage, and tissue, acquired Lynch Biologics, US. The acquisition helped Geistlich Pharma to strengthen its portfolio by adding Lynch Biologics, LLC's leading GEM 21S product to it. GEM 21S is based on a growth factor that accelerates bone formation and wound healing. The companies further aim to innovate regenerative technologies in dentistry. In December 2022, Neoss Group, which designs, manufactures, and sells dental implant treatment products, opened a new sales office in the Nordic region. The facility commenced operations in the Nordic region on December 01, 2022, to support dental professionals and their patients. In January 2021, Dentsply Sirona acquired Datum Dental, a leading provider of innovative OSSIX regenerative solutions. The acquisition enabled Dentsply Sirona to acquire the strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It also offered it access to the patented GLYMATRIX technology of Datum Dental Ltd. GLYMATRIX mimics the natural collagen cycle in the body, i.e., a biochemical process called glycation. GLYMATRIX forms the basis of OSSIX products for guided bone regeneration, as well as guided tissue regeneration.
South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Overview
The South & Central America market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in this region has immense potential for growth owing to factors such as increasing cases of dental diseases, growing dental tourism, and the presence of major market players.
South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Segmentation
The South & Central America dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.
Based on product, the South & Central America dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the South & Central America dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the South & Central America dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the South & Central America dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the South & Central America dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the South & Central America dental bone graft substitute and barrier membrane market in 2022.
Based on country, the South & Central America dental bone graft substitute and barrier membrane market is segmented into Brazil, Argentina and the Rest of South and Central America. The Rest of South and Central America dominated the South & Central America dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, and Institut Straumann AG are some of the leading companies operating in the South & Central America dental bone graft substitute and barrier membrane market.